RecallHawk

PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM)

WYETH PHARMS

Summary

FDA approved PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) by WYETH PHARMS. NDA (New Drug) approval (Labeling) on 2023-07-18. TABLET, DELAYED RELEASE, ORAL.

Details

Source

Drug Approval

External ID

NDA020987-60

Action Date

2023-07-18

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

PROTONIX DELAYED-RELEASE (generic: PANTOPRAZOLE SODIUM), TABLET, DELAYED RELEASE, ORAL. Application: NDA020987

Context & Analysis

WYETH PHARMS has 4 FDA actions in our database.

Frequently Asked Questions

How often does WYETH PHARMS have FDA actions?

WYETH PHARMS has 4 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA020987-60" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions